HMS Liquifilm en es it fr

HMS Liquifilm Brand names, HMS Liquifilm Analogs

HMS Liquifilm Brand Names Mixture

  • No information avaliable

HMS Liquifilm Chemical_Formula


HMS Liquifilm RX_link

HMS Liquifilm fda sheet

HMS_Liquifilm FDA

HMS Liquifilm msds (material safety sheet)

HMS Liquifilm Synthesis Reference

No information avaliable

HMS Liquifilm Molecular Weight

383.464 g/mol

HMS Liquifilm Melting Point

No information avaliable

HMS Liquifilm H2O Solubility


HMS Liquifilm State


HMS Liquifilm LogP


HMS Liquifilm Dosage Forms

Powder for solution (for injection)

HMS Liquifilm Indication

For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.

HMS Liquifilm Pharmacology

Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.

HMS Liquifilm Absorption

No information avaliable

HMS Liquifilm side effects and Toxicity

In mice and rats, large intravenous doses of meropenem (2200-4000 mg/kg) have been associated with ataxia, dyspnea, convulsions, and mortalities.

HMS Liquifilm Patient Information

HMS Liquifilm Organisms Affected

Enteric bacteria and other eubacteria